However, as with any supplement or medication, some side effects can occur
Hypersensitivity reactions may manifest in various ways, ranging from local injection site reactions such as erythema, swelling, and pruritus to more severe systemic reactions including angioedema, anaphylaxis, or generalized urticaria
Common injection sites include the abdomen (avoiding the area immediately around the navel), anterior thigh, or upper arm
Prevention of vitamin B12 deficiency in people who need more vitamin B12 than usual due to certain conditions (such as pregnancy, thyroid problems, liver or kidney problems)
Regulatory Status AOD-9604 is not FDA-approved for any medical use and is listed by the FDA as a bulk drug substance that may present safety risks. Clinical development was halted after Phase IIb trials failed to meet efficacy endpoints. Summary AOD-9604 is a synthetic analog of the HGH 177191 fragment developed for fat-metabolism research
Injections help prevent or reverse this